Lynch syndrome accounts for approximately 3% of CRCs, whereas approximately 12–15% of CRCs is sporadic MSI-H CRC, resulting from hypermethylation of the MLH1 promoter [39]. This evidence concerns the gene MLH1 and colorectal carcinoma.